Patents by Inventor Zhiwei Wang

Zhiwei Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250026766
    Abstract: The present invention relates to compounds containing thiazolopyridyl amide structure, the process for their synthesis, as well as the use of such compounds for inhibiting DNA Polymerase Theta (Pol Theta), and in the treatment of various diseases including cancers.
    Type: Application
    Filed: July 2, 2024
    Publication date: January 23, 2025
    Applicant: BeiGene, Ltd.
    Inventors: Jing Li, Wenqing Xu, Zhiwei Wang
  • Publication number: 20250031307
    Abstract: A power module is disclosed and includes an upper surface for receiving multiple input signals, a lower surface for outputting multiple output signals, a top layer circuit board, a bottom layer circuit board and a middle layer. The top layer circuit board includes a first surface and a second surface disposed opposite to each other, and multiple electronic devices. The first surface forms the upper surface, and multiple first signal connection parts are disposed on the first surface for receiving the multiple input signals. The bottom layer circuit board includes a third surface and a fourth surface disposed oppositely. The fourth surface forms the lower surface, and multiple second signal connection parts are disposed on the fourth surface for outputting the multiple output signals. The middle layer is disposed between the top layer circuit board and the bottom layer circuit board.
    Type: Application
    Filed: June 21, 2024
    Publication date: January 23, 2025
    Inventors: Zhiwei Wang, Quansong Luo, Kaijian Yang, Zhongwang Yang
  • Publication number: 20250025841
    Abstract: The present disclosure relates to a layered bimetallic hydroxide-based hydrogel bipolar membrane and a method for preparing the same. The method includes: blade-coating a quaternized polyethersulfone solution on a substrate, and carrying out drying to obtain an anion exchange layer; immersing the layer sequentially and cyclically in a sodium alginate solution and a first metal ion mixed solution to obtain a hydrogel anion exchange membrane; immersing the hydrogel membrane sequentially in a second metal ion mixed solution and an alkaline solution; and blade-coating a sulfonated polyethersulfone solution on the obtained membrane, and carrying out drying to obtain the layered bimetallic hydroxide-based hydrogel bipolar membrane. The anion and cation exchange membrane layers on two sides of the bipolar membrane prepared in the present disclosure are closely bound by way of hydrogel cross-linking.
    Type: Application
    Filed: December 6, 2023
    Publication date: January 23, 2025
    Inventors: Zhiwei Wang, Wei Shi, Lijun Meng, Xueye Wang
  • Publication number: 20250020882
    Abstract: The present disclosure discloses a cable organizing mechanism, including: a first plate body and a second plate body. When the second plate body is mutually clamped with the first plate body, an opening allowing a joint of a cable to pass through is closed to form at least one a pass-through hole configured to allow the cable to pass through. The present disclosure further includes a cable arranging mechanism, including an extending plate connected with at least one of the first plate body or the second plate body and an auxiliary plate mutually clamped with the extending plate. The present disclosure can solve the problem that after cables between a cabinet and a switch are organized in order, a cable organizing effect is unfavorable, and the cables cannot be completely spaced apart, and quality of project construction is affected.
    Type: Application
    Filed: September 27, 2024
    Publication date: January 16, 2025
    Inventors: Chuanbao Wang, Zhiwei Wang
  • Publication number: 20250019093
    Abstract: The present invention discloses an SMA wire-driven reusable release mechanism having a self-resetting function. The present invention adopts a structure of two-stage load reduction and one-stage release. First-stage load reduction: a compression rod and a hoop petal, as well as an inclined block and a shell or a sliding block, all cooperate with each other by means of inclined surfaces, which can transfer most of tension load of the compression rod to the shell, leaving only a small part of the load transmitted to a thrust bearing. Second-state load reduction: balls in the thrust bearing are coated with a molybdenum disulfide lubricating coating, which can effectively reduce friction so as to reduce a torque transmitted to a driving shaft. First-stage release: the driving shaft drives a thrust bearing to rotate by a certain angle, causing an upper ring of the thrust bearing to descend to release a certain axial clearance.
    Type: Application
    Filed: October 1, 2024
    Publication date: January 16, 2025
    Applicant: Beijing University Of Aeronautics And Astronautics
    Inventors: Xiaojun YAN, Jiaming LENG, Lei QU, Xiaoyuan WANG, Zhiwei LIU, Weifeng WAN, Huimin LI
  • Patent number: 12195449
    Abstract: Disclosed herein is 3-[(1H-pyrazol-4-yl)oxy]pyrazin-2-amine compounds of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of modulating, e.g.
    Type: Grant
    Filed: April 30, 2024
    Date of Patent: January 14, 2025
    Assignee: BeiGene, Ltd.
    Inventors: Sanjia Xu, Jing Li, Zhiwei Wang
  • Publication number: 20250000854
    Abstract: This disclosure provides compounds containing 4-(aminomethyl)-6-(1-methyl-1H-pyrazol-4-yl) isoquinolin-1 (2H)-onestructure, the use thereof for selectively inhibiting the activity of PRMT5 in cooperative with MTA in tumors bearing MTAPDEL mutation, and pharmaceutical compositions comprising the compounds as treatment of various diseases including cancer.
    Type: Application
    Filed: September 5, 2024
    Publication date: January 2, 2025
    Applicant: BeiGene, Ltd.
    Inventors: Sanjia XU, Jing LI, Zhiwei WANG
  • Publication number: 20240425523
    Abstract: Disclosed herein are novel bifunctional compounds formed by conjugating EGFR inhibitor moieties with E3 ligase ligand moieties, methods of preparation, and uses thereof.
    Type: Application
    Filed: May 30, 2024
    Publication date: December 26, 2024
    Inventors: Huaqing Liu, Bailin Lei, Yizhou Zhao, Xinzhu Qi, Guanjun Liu, Zhiwei Wang
  • Publication number: 20240408552
    Abstract: The present invention belongs to the technical field of membrane-based water treatment and relates to a novel guanidine-based composite nanofiltration (NF) flat-sheet membrane, and a preparation method and application thereof. The present invention provides a method for preparing a guanidine-based composite NF flat-sheet membrane, where a dense separation layer is formed on the surface of a polyethersulfone ultrafiltration membrane through polymerization reaction between the amino group of 1,3-diaminoguanidine and the acyl chloride group of trimesoyl chloride. Under suitable reaction conditions, the guanidine-based composite NF membrane obtained according to the present invention enables effective separation of multivalent ions over a wide pH range, with a rejection rate of over 96% for 1000 ppm of MgSO4 solution, and can operate continuously and stably in a mixed ions solution with a wide pH.
    Type: Application
    Filed: February 5, 2024
    Publication date: December 12, 2024
    Applicant: TONGJI UNIVERSITY
    Inventors: Qiaoying WANG, Tong ZHANG, Zhiwei WANG, Hao ZHANG, Rong HUANG, Xianfeng LI
  • Publication number: 20240409546
    Abstract: The present invention relates to a crystalline form of(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetr a-hydropyrazolo [1,5-a]pyrimi dine-3-carboxamide for inhibiting Btk, methods of preparation thereof and pharmaceutical compositions, and use of the crystalline form above in the treatment of a disease, or in the manufacturing of a medicament for the treatment of a disease.
    Type: Application
    Filed: August 21, 2024
    Publication date: December 12, 2024
    Inventors: Zhiwei WANG, Yunhang Guo, Gongyin Shi
  • Patent number: 12158022
    Abstract: A gap caulking device and a caulking method are provided, wherein the gap caulking device includes long plates, short plates, a dial plate, a three-way joint, a tensioner and a limit rod, and a closed quadrilateral structure with an adjustable angle is formed by two long plates hinged to each other and two short plates hinged to each other, a dial plate and a pointer are respectively provided on the two short plates, damping rods hinged on the two short plates to each other and a three-way joint matched with the two long plates are passed through by a limit rod to achieve connection limiting, and a shape memory alloy wire is connected to the three-way joint by a tensioner and is parallel to the limit rod. The problem is overcome that the original traditional wedge-shaped material that gaps rely on has a single filling function.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: December 3, 2024
    Assignee: CHINA THREE GORGES CORPORATION
    Inventors: Chao Gao, Yantong Dong, Zhiwei Wang, Jie Yu
  • Publication number: 20240376097
    Abstract: Disclosed herein is a compound of Formula (I) for inhibiting both Bcl-2 wild type and mutated Bcl-2, in particular, Bcl-2 G101V and D103Y, and a method of using the compound disclosed herein for treating dysregulated apoptotic diseases.
    Type: Application
    Filed: March 1, 2024
    Publication date: November 14, 2024
    Applicant: BeiGene Ltd.
    Inventors: Hai Xue, Yunhang Guo, Zhiwei Wang
  • Publication number: 20240376104
    Abstract: Disclosed herein is a compound of Formula (I) for inhibiting Bcl-2 and treating disease associated with undesirable bcl-2 activity (Bcl-2 related diseases), a method of using the compounds disclosed herein for treating dysregulated apoptotic diseases including cancers and treating autoimmune disease, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: June 17, 2024
    Publication date: November 14, 2024
    Applicant: BeiGene Ltd.
    Inventors: Yunhang Guo, Hai Xue, Zhiwei Wang, Hanzi Sun
  • Publication number: 20240368203
    Abstract: Disclosed herein are novel bifunctional compounds formed by conjugating EGFR inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof.
    Type: Application
    Filed: July 12, 2024
    Publication date: November 7, 2024
    Applicant: BeiGene, Ltd.
    Inventors: Bailin LEI, Huaqing LIU, Songzhe HAN, Yizhou ZHAO, Zhiwei WANG
  • Publication number: 20240366770
    Abstract: Disclosed herein are novel bifunctional compounds formed by conjugating BTK inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof.
    Type: Application
    Filed: June 28, 2024
    Publication date: November 7, 2024
    Applicant: BeiGene Switzerland GmbH
    Inventors: Changxin HUO, Hexiang WANG, Zhemin CHEN, Zhiwei WANG, Huaqing LIU
  • Publication number: 20240366769
    Abstract: Disclosed herein are novel bifunctional compounds formed by conjugating BTK inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof.
    Type: Application
    Filed: June 28, 2024
    Publication date: November 7, 2024
    Applicant: BeiGene Switzerland GmbH
    Inventors: Changxin HUO, Hexiang WANG, Ruipeng QI, Zhiwei WANG, Huaqing LIU
  • Publication number: 20240368177
    Abstract: This disclosure provides 5-amino-6,8-dihydro-1H-furo[3,4-d]pyrrolo[3,2-b]pyridine-2-carboxamide derivatives, the use thereof for selectively inhibiting the activity of PRMT5 in cooperation with MTA in tumors bearing MTAPDEL mutation, and pharmaceutical compositions comprising the compounds, e.g., for treatment of various diseases including cancer.
    Type: Application
    Filed: March 27, 2024
    Publication date: November 7, 2024
    Applicant: BeiGene Switzerland GmbH
    Inventors: Jing LI, Sanjia Xu, Yian Guo, Zhiwei Wang
  • Patent number: 12135110
    Abstract: A large-dip-angle self-leveling device is provided. The device comprises a mounting base platform arranged on a mounting stand column and a support cylinder connected with the mounting base platform. A leveling plate is arranged at the top of the mounting base platform, and a leveling platform is arranged on the leveling plate. A spirit bubble indicator and a control circuit board are arranged on the leveling platform. A connecting rod of balance weight is arranged in the support cylinder, one end of the connecting rod of balance weight is connected with the leveling platform, and the other end is connected with a balance weight. A four-core cable penetrates through the connecting rod of balance weight and the balance weight. Observation windows are symmetrically arranged at the lower part of the support cylinder. A melting pool is arranged at the bottom in the support cylinder.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: November 5, 2024
    Assignee: Northwest Institute of Eco-Environment and Resources, Chinese Academy of Sciences
    Inventors: Ji Chen, Youqian Liu, Haiming Dang, Jiexuan Kang, Shouhong Zhang, Jinchang Wang, Guilong Wu, Tianchun Dong, Zhiwei Wang, Yaojun Zhao
  • Patent number: 12121837
    Abstract: A method for recycling a scrapped polyvinylidene fluoride (PVDF) membrane through chemical cleaning-structural transformation-hydrophilicity is disclosed, which can extend the service life of scrapped PVDF membrane materials (namely, membrane at the end of service life). The method includes the following steps: cleaning a scrapped membrane with sodium hypochlorite and citric acid; treating the membrane with a structural transformation agent, where, irreversible contaminants are washed away while the PVDF membrane is subjected to pore expansion and hydrophilization; and with self-polymerization of dopamine on a membrane surface, further improving the hydrophilicity of the membrane surface, enhancing the anti-contamination performance, and repairing damaged points on the surface of the scrapped PVDF membrane produced during long-term operation.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: October 22, 2024
    Assignee: TONGJI UNIVERSITY
    Inventors: Zhiwei Wang, Chenxin Tian, Ruobin Dai, Tianlin Wang, Jiansuxuan Chen
  • Publication number: 20240342292
    Abstract: Disclosed herein are novel bifunctional compounds formed by conjugating EGFR inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof.
    Type: Application
    Filed: May 29, 2024
    Publication date: October 17, 2024
    Applicant: BeiGene Switzerland GmbH
    Inventors: Bailin Lei, Huaqing Liu, Songzhe Han, Yizhou Zhao, Zhiwei Wang, Guanjun Liu, Haijun Liu